ID   K-3502
AC   CVCL_B7RP
DR   Wikidata; Q112929922
RX   PubMed=18802091;
CC   Population: Caucasian.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Gln136fs*13 (c.406_407insC); Zygosity=Homozygous (from parent cell line).
CC   Transfected with: HGNC; 4932; HLA-B (allele B*35:02).
CC   Transfected with: UniProtKB; P13249; S.alboniger pac (PuroR).
CC   Omics: HLA class I peptidome analysis by proteomics.
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
DI   NCIt; C9110; Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0004 ! K-562
SX   Female
AG   53Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=18802091; DOI=10.4049/jimmunol.181.7.4874;
RA   Escobar H., Crockett D.K., Reyes-Vargas E., Baena A., Rockwood A.L.,
RA   Jensen P.E., Delgado J.C.;
RT   "Large scale mass spectrometric profiling of peptides eluted from HLA
RT   molecules reveals N-terminal-extended peptide motifs.";
RL   J. Immunol. 181:4874-4882(2008).
//